Investing.com - STAAR Surgical (NASDAQ: STAA) reported third quarter EPS of $0.20, $0.02 better than the analyst estimate of $0.18. Revenue for the quarter came in at $88.6M versus the consensus estimate of $86.9M.
Guidance
STAAR Surgical sees FY 2024 revenue of $340.00M-$345.00M versus the analyst consensus of $343.40M.
STAAR Surgical's stock price closed at $29.49. It is down -24.38% in the last 3 months and down -29.48% in the last 12 months.
STAAR Surgical saw 1 positive EPS revisions and 4 negative EPS revisions in the last 90 days. See STAAR Surgical's stock price’s past reactions to earnings here.
According to InvestingPro, STAAR Surgical's Financial Health score is "good performance".
Check out STAAR Surgical's recent earnings performance, and STAAR Surgical's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar